The estimated annual financial impact of gene therapy in the United States.

Gene Ther · 2023 · PMC10678302 · PMID 37935855

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

While the prices of individual gene therapies may be justified by their clinical benefits, spending in aggregate across all available gene therapies may be significant for payers, depending on the number of patients treated per year.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.